Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model

Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model

Widespread and rapidly evolving SARS-CoV-2 posed an unprecedented challenge to vaccine developers. GeoVax has designed a multiantigen SARS-CoV-2 vaccine, designated GEO-CM02 based on a Modified Vaccinia Virus (MVA) vector that expresses spike (S), membrane (M), and envelope (E) antigens. This experi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shannon Stone, Amany Elsharkawy, J. D. Burleson, Mary Hauser, Arban Domi, Pratima Kumari, Zainab Nabi, Janhavi P. Natekar, Maciel Porto, Brian Backstedt, Mark Newman, Sreenivasa Rao Oruganti, Mukesh Kumar
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Vaccines
Subjects:	SARS-CoV-2 COVID-19 MVA-VLP
Online Access:	https://www.mdpi.com/2076-393X/13/4/411
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Fast and High-Accuracy Real-Time Visible Light Positioning System Based on Single LED Lamp With a Beacon
by: Huaping Li, et al.
Published: (2020-01-01)

Immunogenic and Protective Features of the Recombinant Vaccinia Virus Strain Expressing Cassette of Genes of Marburg Virus Structural Proteins
by: A. V. Semenova, et al.
Published: (2022-01-01)

Análisis de Creación de Valor Económico para Empresas del Sector Textil (Value added analysis for the textile sector businesses)
by: Diego Valerio Alfaro, et al.
Published: (2012-12-01)

ANALISIS KINERJA KEUANGAN DENGAN MENGGUNAKAN METODE MARKET VALUE ADDED (MVA) PADA PT. ELECTRONIC CITY INDONESIA TBK YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2019-2023
by: Muhammad Hariv Al Akbar Akbar, et al.
Published: (2024-12-01)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
by: Raveen Rathnasinghe, et al.
Published: (2020-01-01)

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines
by: Getahun Abate, et al.
Published: (2025-05-01)

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus
by: Luis Jiménez-Cabello, et al.
Published: (2025-05-01)

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
by: Zhen Zhang, et al.
Published: (2024-12-01)

Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations
by: Clara Suñer, et al.
Published: (2025-05-01)

Sistema innovador de cultivos in vitro inoculados con simbiontes rizosférico MVA y bacterias surfactantes como fitoremediador de suelos contaminados con agrotóxicos
by: Francisco Angel Simòn Ricardo, et al.
Published: (2017-09-01)

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses
by: Patricia Pérez, et al.
Published: (2021-01-01)

Development and Application of Indirect ELISA for IBDV VP2 Antibodies Detection in Poultry
by: Wenying Zhang, et al.
Published: (2025-06-01)

A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV)
by: Jixiang Gu, et al.
Published: (2025-07-01)

Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein
by: Debora Patricia Garanzini, et al.
Published: (2025-03-01)

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01)

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge
by: Gerald K. Chege, et al.
Published: (2025-02-01)

Evaluation of Anti-HPV18 Antibody Titers Preceding an Incident Cervical HPV18/45 Infection
by: Fanua Wiek, et al.
Published: (2025-07-01)

Immunogenicity of Matrix Protein 2 Ectodomain (M2e) Displayed on Nodavirus-like Particles as Avian Influenza Vaccine for Poultry
by: Anis Suraya Mohamad Abir, et al.
Published: (2025-06-01)

Non-line-of-sight Visible Light Positioning System based on Deep Learning
by: HUANG Weijie, et al.
Published: (2024-12-01)

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial
by: Neil Goldstein, et al.
Published: (2024-12-01)

Development and characterization of a fully humanized ACE2 mouse model
by: Chunyu Ge, et al.
Published: (2025-07-01)

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice
by: Mayara Mattos, et al.
Published: (2024-11-01)

A study of the safety and immunogenicity of a new vaccine for the prevention of COVID-19 based on virus-like particles in phase I clinical trials
by: Tatiana V. Grebennikova, et al.
Published: (2025-05-01)

Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications
by: Yu Chen, et al.
Published: (2024-12-01)

Optimizing the production of recombinant human papilloma virus type 52 major capsid protein L1 in Hansenula polymorpha
by: Wichittra Phimsen, et al.
Published: (2024-11-01)

Personalized immunization against Mpox Clades I and Ib: Strategies to combat the emerging epidemic
by: Deepak Kumar, et al.
Published: (2025-03-01)

Cervical Spine Injuries and Maxillofacial Trauma: A Systematic Review
by: Feras AlMofreh, DDS, et al.
Published: (2021-12-01)

The Role of Acute Hyperglycemia on the Risk of Malignant Arrhythmia in Acute Myocardial Infarction Patients: A Study of Myocardial Damage, Ion Channel Changes and Inflammatory Factors
by: Sally Aman Nasution, et al.
Published: (2020-08-01)

The Role of Acute Hyperglycemia on the Risk of Malignant Arrhythmia in Acute Myocardial Infarction Patients: A Study of Myocardial Damage, Ion Channel Changes and Inflammatory Factors
by: Sally Aman Nasution, et al.
Published: (2020-08-01)

Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?
by: Reeshu Gupta, et al.
Published: (2024-12-01)

Pre-Existing Anti-Vector Immunity to Adenovirus-Inspired VLP Vaccines Shows an Adjuvant-Dependent Antagonism
by: Salomé Gallet, et al.
Published: (2025-02-01)

MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination
by: Anna D. Kosinska, et al.
Published: (2025-09-01)

Influences of metabolism and lipid homeostasis on regulatory vs. conventional T cells and implications for autoimmunity
by: Madison A. Nguyen, et al.
Published: (2025-07-01)

Synergizing Machine Learning and Physical Models for Enhanced Gas Production Forecasting: A Comparative Study of Short- and Long-Term Feasibility
by: Bafren K. Raoof, et al.
Published: (2025-02-01)

Novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle
by: Yulong Wang, et al.
Published: (2024-12-01)

BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators
by: Renju Pun, et al.
Published: (2025-03-01)

B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2
by: Beatriz Perdiguero, et al.
Published: (2024-10-01)

Design and construction of a fast synthetic modified vaccinia virus Ankara reverse genetics system for advancing vaccine development
by: Zhiqiang Gao, et al.
Published: (2025-04-01)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
by: Claude Kwe Yinda, et al.
Published: (2021-01-01)

Angle-of-Arrival (AOA) Visible Light Positioning (VLP) System Using Solar Cells With Third-Order Regression and Ridge Regression Algorithms
by: Chong-You Hong, et al.
Published: (2020-01-01)